David E. Kang
Impact in
- Physiology top 0.5%
- Alzheimer's disease research and treatments
- Neurology top 1%
- Parkinson's Disease Mechanisms and Treatments
- Neuroinflammation and Neurodegeneration Mechanisms
Papers in
-
- Mitochondrial Function and Pathology 8
- Wnt/β-catenin signaling in development and cancer 6
- S100 Proteins and Annexins 6
- Physiology 44
- Alzheimer's disease research and treatments 41
- Co-authors
- Edward H. Koo (16 shared papers)Jung A. Woo (35 shared papers)Claus U. Pietrzik (3 shared papers)Salvador Soriano (5 shared papers)Eliezer Masliah (6 shared papers)Yu Xia (3 shared papers)Sarah A. Sagi (1 shared paper)Thomas Bülter (1 shared paper)
- Journals
- Journal of Biological Chemistry (6 papers)The FASEB Journal (6 papers)Proceedings of the National Academy of Sciences (3 papers)Cell Death and Disease (3 papers)The Journal of Urology (3 papers)
- Partner nations
- United StatesFranceSouth Korea
In The Last Decade
David E. Kang
73 papers receiving 5.2k citations
David E. Kang's Hit Papers
Peers
Comparison fields: 5 of 127
- Physiology 3.0k
- Neurology 684
- Biological Psychiatry 177
- Cellular and Molecular Neuroscience 1.2k
- Pharmacology 856
Countries citing papers authored by David E. Kang
This map shows the geographic impact of David E. Kang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David E. Kang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David E. Kang more than expected).
Fields of papers citing papers by David E. Kang
This network shows the impact of papers produced by David E. Kang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David E. Kang. The network helps show where David E. Kang may publish in the future.
Co-authors
The 25 scholars most cited alongside David E. Kang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 75 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A subset of NSAIDs lower amyloidogenic Aβ42 independently of cyclooxygenase activity Hit paper breakdown → | 2001 | 1103 |
| 2 | 1997 | 312 | |
| 3 | 2000 | 301 | |
| 4 | 1997 | 260 | |
| 5 | 2002 | 198 | |
| 6 | 2004 | 196 | |
| 7 | 2010 | 181 | |
| 8 | 2001 | 174 | |
| 9 | 1995 | 170 | |
| 10 | 1999 | 161 | |
| 11 | 1999 | 142 | |
| 12 | 2005 | 115 | |
| 13 | 2005 | 98 | |
| 14 | 2017 | 89 | |
| 15 | 2022 | 83 | |
| 16 | 2007 | 83 | |
| 17 | 2012 | 82 | |
| 18 | 2008 | 81 | |
| 19 | 2015 | 75 | |
| 20 | 2009 | 74 |
About David E. Kang
David E. Kang is a scholar working on Molecular Biology, Physiology, Cellular and Molecular Neuroscience, Cell Biology and Neurology, having authored 75 papers that have together received 5.3k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (41 papers), Cellular transport and secretion (10 papers), Mitochondrial Function and Pathology (8 papers), Wnt/β-catenin signaling in development and cancer (6 papers), Amyotrophic Lateral Sclerosis Research (6 papers), S100 Proteins and Annexins (6 papers), Parkinson's Disease Mechanisms and Treatments (6 papers) and Nuclear Receptors and Signaling (6 papers). The work is most often cited by research in Physiology (3.0k citations), Neurology (684 citations), Biological Psychiatry (177 citations), Cellular and Molecular Neuroscience (1.2k citations) and Pharmacology (856 citations). David E. Kang has collaborated with scholars based in United States, France and South Korea. Frequent co-authors include Edward H. Koo, Jung A. Woo, Claus U. Pietrzik, Salvador Soriano, Eliezer Masliah, Yu Xia, Sarah A. Sagi, Thomas Bülter, Michael P. Murphy and Sascha Weggen. Their work appears in journals such as Journal of Biological Chemistry, The FASEB Journal, Proceedings of the National Academy of Sciences, Cell Death and Disease and The Journal of Urology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.